Furthermore, gastric cancer patient with EBV+ and MSI tend to show PD-L1 expression, which demonstrated that specifically EBV+ GC and MSI may be prime candidates for PD-L1 directed therapy. The gene discussed is CD274; the disease is gastric cancer.